DOVER, DE (October 14, 2022) – The Delaware Division of Public Health (DPH) reports that the 7-day average of new positive COVID-19 cases has decreased for the third consecutive month. Deaths remain low, and hospitalization rates are holding steady. According to the Centers for Disease Control and Prevention’s (CDC) COVID-19 Community Levels data tracker, which factors in data on hospitalizations and cases in each county to determine recommended community prevention strategies, COVID-19 community levels in Kent County are now high, Sussex County remains at medium, while levels in New Castle County continue to be listed as low as of October 13.    

 

This week, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization to Pfizer for the bivalent booster for ages 5-11 and to Moderna for their bivalent booster for those ages 6-17 who have received their primary series of vaccination at least two months before (a minimum of two doses of Pfizer, Moderna or Novavax). The CDC Director also signed off on the expanded authorization.  Bivalent boosters were previously authorized on Aug. 31 for those ages 12+ for Pfizer, and for Moderna, ages 18+.  Moderna’s bivalent booster for ages 5-11 will utilize the same product as the adult booster, just at a lesser dose. Pfizer’s bivalent booster for youth will come in a separate vial as it requires dilution, while the adult formula does not, for more information, visit de.gov/boosters. 

 

The updated boosters target two strains of COVID-19: the original strain of the virus, and two of the Omicron variants (BA.4 and BA.5), currently, the most widespread variants in the world. To reduce confusion among the public and vaccine providers, and because they do not offer the increased levels of protection provided by the bivalent boosters, the original (monovalent) booster formula is no longer authorized for use in those 5 and older. Medical providers may no longer administer them. Individuals who have recently had COVID-19 are strongly encouraged to get a bivalent booster to optimize their protection, even if they received a monovalent booster before. Those who recently had COVID-19 should also get the new booster but should consider waiting three months after they have recovered from the virus.  

 

DPH strongly encourages everyone to get their bivalent booster as soon as they are eligible, and well in advance of any possible surge in the late fall or winter.   A recent Commonwealth Fund study found that if 80% of eligible individuals 5 and older receive their booster dose by the end of 2022, it would prevent about 90,000 deaths and more than 936,000 hospitalizations, while also preventing $56 billion in medical costs in the next six months. However, if the current pace of vaccinations remains unchanged nationwide through March 2023, a potential winter surge in the United States could result in as many as 16,000 hospitalizations and 1,200 deaths per day, the study found.  

 

Individuals may also get a booster at the same time as they get their annual flu vaccine, either in the same arm at least one inch apart, or in different arms. The Centers for Disease Control and Prevention encourages everyone 6 months older to get their flu vaccine by Halloween amid concerns of a potentially severe flu season. This week, DPH confirmed that flu is statewide and has already recorded the state’s first pediatric case of the season as well. Flu vaccines and bivalent boosters are available at DPH clinics, many pharmacies, Federally Qualified Health Centers and some community events. You can find a list of locations for COVID vaccines at de.gov/getmyvaccine. or at vaccines.gov. Locations for flu vaccines can be found on the flu finder on the flu.delaware.gov webpage. More details on the bivalent booster can be found at de.gov/boosters.  

 

The webpage also has a link to a flier for the public which highlights some similarities between the labels of bivalent boosters and some primary series vaccines. Those getting a booster are encouraged to print and take a copy of the flier with them, or pull it up on their phone’s web browser, and ask the vaccine provider to show them the vial that your bivalent booster is being drawn from so they can confirm it is the correct one. It is an important step in being an educated health consumer and advocate for your personal health.  

 

The below data is as reported on Delaware’s My Health Community data portal on Thursday, Oct. 13, 2022.  

 

COVID-19 Cases and Hospitalizations:  

• Total positive cases since March 11, 2020: 310,819*
• 7-day daily average of new positive cases: 146.4, a decrease of 49.7 average new positive cases reported since Sept 15, 2022  
• 7-day daily average for the percentage of total positive tests: 9.9 percentage points, a decrease of 2.6 percentage points reported since Sept. 15, 2022  
• Hospitalizations: 105 current hospitalizations; critically ill: 8
• Total COVID-19 deaths: 3,121, an increase of 41 since last month including 35 as a result of ongoing Vital Statistics reviews of deaths occurring between June and September.*Case and testing data are based on reporting of lab-confirmed COVID-19 tests only. The number of COVID-19 cases in the community is higher than what is reported because of the use of at-home test kits.  

COVID-19 Vaccinations:  

• Total number of doses administered in Delaware: 1,973,133
• Percentage of Delawareans 5+ who are fully vaccinated (CDC data): 75.7%  
• Percentage of Delawareans 12+ who are fully vaccinated (CDC data): 79.8%  
• Percentage of Delawareans 18+ who are fully vaccinated (CDC data): 81.3%  
• Percent of Delawareans who are fully vaccinated (CDC data): 71.6%  

All qualifying Delawareans should get vaccinated. For a location near you, visit de.gov/getmyvaccine. Delaware’s latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healthycommunity.  

COVID-19 Case Vaccination Status Report:  

The following reports capture a weekly breakdown of non-boosted cases, deaths, and hospitalizations for the time frame of Sep 26 – Oct 2, 2022.  
  

Non-boosted: Case – Hospital – Death

Weekly Overview (09/26/22 – 10/02/22)
Non-boosted Cases
Total Non-boosted Cases	819
Total Cases	1269
Percent of Non-boosted Cases	64%
Non-boosted Hospitalized Cases
Total Non-boosted Hospitalized Cases	95
Total Hospitalized Cases	140
Percent of Non-boosted Cases	68%
Non-boosted Deaths
Total Non-boosted Deaths	1
Total COVID-19 Deaths	1
Percent of Non-boosted Deaths	100%

 

Note: Case and Hospitalization Count: based on RTS (Report to State Date) Death: based on DoD (Date of Death)  

  

Long-term Care Statistics:  

As of Thursday, October 13, 2022, there have been a total of 4,705 positive COVID-19 cases involving long-term care residents, and 989 residents of Delaware long-term care facilities have died from complications related to COVID-19. 

 

Resources:  

Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:  

 

• Monday – Friday: 8:00 a.m. to 9:00 p.m.  
• Saturday: 9:00 a.m. to 5:00 p.m.  

Medically related questions regarding testing, symptoms, and health-related guidance can be submitted by email at DPHCall@delaware.gov.  

DPH will continue to update the public as more information becomes available. For the latest on Delaware’s response, go to de.gov/coronavirus.  

 

### 

 

The Delaware Division of Public Health (DPH), a division of the Delaware Department of Health and Social Services, is a nationally accredited public health agency recognized by the Public Health Accreditation Board for its outstanding dedication to driving change through innovation. DPH is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.  

  

A person who is deaf, hard-of-hearing, deaf-blind or speech-disabled can call the DPH phone number above by using TTY services. Dial 7-1-1 or 800-232-5460 to type your conversation to a relay operator, who reads your conversation to a hearing person at DPH. The relay operator types the hearing person’s spoken words back to the TTY user. To learn more about TTY availability in Delaware, visit http://delawarerelay.com. 

DOVER, DE (September 16, 2022) – The Delaware Division of Public Health (DPH) is pleased to share declines in hospitalizations, test positivity rates and the 7-day average of new positive COVID-19 cases continued for the second month in a row.  Deaths also remain low. However, COVID-19 is still circulating in the community, and at higher levels in some counties. Additionally, while hospitalizations overall are down, in recent weeks they have increased in the 0-4 months age range and the 18-34 years age range.  According to the Centers for Disease Control and Prevention’s (CDC) COVID-19 Community Levels data tracker, which was last updated on September 15, COVID-19 community levels in Kent and Sussex counties are considered medium, while levels in New Castle County are listed as low.

Recently, the Food and Drug Administration (FDA) and CDC have authorized the new bivalent boosters from Pfizer BioNTech and Moderna, which target two strains of COVID 19: the original strain of the virus, and two of the Omicron variants (BA.4 and BA.5), currently, the most widespread variants in the world.  The updated bivalent boosters are available to all individuals 12 years of age and older who have received their primary series of vaccination at least two months before (a minimum of two doses of Pfizer, Moderna or Novavax and one dose of Johnson and Johnson).  Individuals who have recently had COVID-19 are still encouraged to get a booster to optimize their protection but should consider waiting three months after they have recovered.

Changes in the virus necessitated new, updated boosters to improve protection. To reduce confusion among the public and vaccine providers, and because they do not offer the increased levels of protection provided by the bivalent boosters, the original booster formula is no longer authorized for use in those 12 and older.  Medical providers may no longer administer them to anyone older than 12.

By authorizing the vaccines in September rather than waiting until later this fall, the CDC estimates the prevention of over 137,000 hospitalizations and 9,200 deaths in the first two months alone. To further support the effectiveness of vaccines and boosters in reducing serious illness, a study of the Journal of the American Medical Association indicates that during the original Omicron surge earlier this year, unvaccinated individuals were 10.5 times more likely to be hospitalized than those who were vaccinated and boosted.

 

Pfizer-BioNTech boosters are authorized for ages 12 and older, while Moderna is authorized for 18 years of age and older.  Regardless of which brand of vaccine you previously received, you can get any bivalent booster for which you are eligible.  As of this time, only the monovalent boosters targeting the original strain are available for children 5 through 11 years of age.  Parents are encouraged to vaccinate their children now with the primary series and most current boosters when eligible until the bivalent boosters are authorized for this age group. With the rise in hospitalizations among those ages 0 – 4 years old, parents of young children are particularly encouraged to get their children vaccinated.

DPH strongly encourages everyone 12 and older to get their bivalent booster as soon as they are eligible, and well in advance of any possible surge in the late fall or winter. Individuals may also get a booster at the same time as they get their annual flu vaccine, but it is recommended to do so in different arms.  Bivalent boosters are available at DPH clinics, many pharmacies, Federally Qualified Health Centers and some community events.  You can find a list of locations at de.gov/getmyvaccine or at vaccines.gov. More details on the bivalent booster can be found at de.gov/boosters.

The webpage also has a link to a flier for the public which highlights some similarities between the labels of bivalent boosters and some primary series vaccines. Those getting a booster are encouraged to print and take a copy of the flier with them, or pull it up on their phone’s web browser, and ask the vaccine provider to show you the vial that your bivalent booster is being drawn from so you can confirm it is the correct one. It is an important step in being an educated health consumer and advocate for your personal health.

The below data is as reported on Delaware’s My Health Community data portal on Thursday, Sept. 15, 2022. 

COVID-19 Cases and Hospitalizations: 

• Total positive cases since March 11, 2020: 305,517*
• 7-day daily average of new positive cases: 196.1, a decrease of 83.3 average new positive cases reported since Aug 18, 2022 
• 7-day daily average for the percentage of total positive tests: 12.5 percentage points, a decrease of 5.9 percentage points reported since Aug 18, 2022 
• Hospitalizations: 121 current hospitalizations; critically ill: 14 
• Total COVID-19 deaths: 3,080, an increase of 44 since last month (11 regularly reported, and 33 from a review of Vital Statistics between June and August)

*Case and testing data are based on reporting of lab-confirmed COVID-19 tests only. The number of COVID-19 cases in the community is higher than what is reported because of the use of at-home test kits. 

COVID-19 Vaccinations:   

• Total number of doses administered in Delaware: 1,893,787
• Percentage of Delawareans 5+ who are fully vaccinated (CDC data): 75.1%  
• Percentage of Delawareans 12+ who are fully vaccinated (CDC data): 79.2%   
• Percentage of Delawareans 18+ who are fully vaccinated (CDC data): 80.7%
• Percent of Delawareans who are fully vaccinated (CDC data): 70.9% 

All qualifying Delawareans should get vaccinated. For a location near you, visit de.gov/getmyvaccine. Delaware’s latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healthycommunity.  

  

COVID-19 Case Vaccination Status Report: 

The following reports capture a weekly breakdown of non-boosted cases, deaths, and hospitalizations for the time frame of Sept 5 – Sept 11, 2022.  

 Non-boosted: Case – Hospital – Death

Weekly Overview (09/05/22 – 09/11/22)
Non-boosted Cases
Total Non-boosted Cases	886
Total Cases	1288
Percent of Non-boosted Cases	64%
Non-boosted Hospitalized Cases
Total Non-boosted Hospitalized Cases	84
Total Hospitalized Cases	136
Percent of Non-boosted Hospitalized Cases	61%
Non-boosted Deaths
Total Non-boosted Deaths	0
Total COVID-19 Deaths	1
Percent of Non-boosted Deaths	0%

 

Note:

Case and Hospitalization Count: based on RTS (Report to State Date)
Death: based on DoD (Date of Death)

 

Long-term Care Statistics:   

As of Thursday, September 15, 2022, there have been a total of 4,573 positive COVID-19 cases involving long-term care residents, and 979 residents of Delaware long-term care facilities have died from complications related to COVID-19.

Resources:   

Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:   

• Monday – Friday: 8:00 a.m. to 9:00 p.m.   
• Saturday: 9:00 a.m. to 5:00 p.m.

 Medical-related questions regarding testing, symptoms and health-related guidance can be submitted by email at DPHCall@delaware.gov.   

DPH will continue to update the public as more information becomes available. For the latest on Delaware’s response, go to de.gov/coronavirus.

###

The Delaware Division of Public Health (DPH), a division of the Delaware Department of Health and Social Services, is a nationally accredited public health agency recognized by the Public Health Accreditation Board for its outstanding dedication to driving change through innovation. DPH is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.  Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com.

DOVER, DE (August 31, 2022) – On Aug. 31, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization to Pfizer and Moderna for their new bivalent boosters, meaning vaccine could start shipping to states that pre-ordered as early as Friday.  The Centers for Disease Control and Prevention’s (CDC) advisory committee meets Thursday and Friday, Sept. 1 and 2, to discuss specifics regarding who should receive the boosters.  The committee is expected to vote during that time, and if approved, a formal sign-off is then required from the CDC director before vaccine administration can begin.

The Division of Public Health (DPH) has preordered approximately 17,000 doses of the bivalent boosters for DPH clinics and enrolled medical providers, in addition to the supply being sent directly to pharmacies and Federally Qualified Health Centers. Delivery is expected later this week or early next week with administration potentially beginning soon after Labor Day or the following week. 

The Moderna and Pfizer bivalent boosters both target two strains of COVID-19 – the original strain of the virus and two of the Omicron variants (BA.4 and BA.5), the current most widespread variants in the world.  Only individuals who have completed their primary vaccination series (two doses of Pfizer or Moderna or one dose of Johnson & Johnson) are eligible to receive the bivalent booster.  Those who have recently received Novovax are not yet eligible for any booster at this time.

“Should the CDC Advisory Committee and the CDC Director sign off on authorizing the use of bivalent boosters, this will be another important step forward in keeping Delawareans protected against serious outcomes from COVID-19,” said DPH Interim Director Dr. Rick Hong. “Delaware providers are well-positioned to begin administering the bivalent booster within a few days of the final approval being given.” 

If you have not been vaccinated or have not completed your primary series, visit de.gov/getmyvaccine for a list of locations offering vaccine. The original formulations of Pfizer, Moderna, J&J and Novovax will continue to be used.  Booster doses use reduced amounts of the original vaccines.

Individuals are eligible for the bivalent booster two months since their last primary or booster dose of any vaccine.  As of today, the current monovalent booster will not be available to persons 12 and older; the FDA is removing authorization for those boosters to reduce provider confusion for staff administering vaccines.

The Pfizer bivalent booster is currently authorized for ages 12 and older while Moderna’s is currently authorized for 18 years of age and older.  Individuals may choose to receive either the Pfizer or Moderna bivalent booster, regardless of which primary series vaccine or original booster dose they had previously.   

Authorization for administration to those under age 12 is expected in the near future, but the timeline is not yet clear.  Parents are encouraged to have their children complete the primary series of the current vaccines so that they will be eligible for the bivalent booster in the future.  In August, while there was a decrease in COVID-related hospitalizations for most adult age groups, hospitalizations for all youth age groups increased, demonstrating the importance of young children becoming fully vaccinated as soon as possible to prevent serious illness, hospitalization, and death.  As such, parents of children under 12 should consider having them receive the original booster at this time to increase their defenses against the virus with back to school and other group activities now occurring.

For the latest information on bivalent boosters, visit de.gov/boosters.  When locations begin administering the bivalent booster, updated information will be available at de.gov/getmyvaccine on how and where to obtain a booster. Information on all things COVID-19 can be found at the DPH website de.gov/coronavirus.  COVID-19 data for Delaware is available at https://myhealthycommunity.dhss.delaware.gov/locations/state.

###

Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e. TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com.

Delaware Health and Social Services is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.

DOVER, DE (July 15, 2022) – The Delaware Division of Public Health (DPH) reports that COVID-19 cases experienced an uptick in the daily 7-day average for the percentage of positive tests since the previous monthly COVID-19 update released on June 17, 2022.  Since that time, Delaware has also exceeded 3,000 COVID-related deaths. According to the Centers for Disease Control and Prevention’s (CDC) COVID-19 Community Levels data tracker, which was last updated on June 14, case levels in Kent County are considered high, while case levels in New Castle and Sussex Counties are listed as medium.

Many people are expressing concerns about getting vaccinated or boosted now, both because of reported lack of effectiveness against the circulating BA.5 variant and the expected updated vaccines in the fall. Regarding the BA.5 variant, approximately 67% of vaccines sequenced from mid-to late June contained a variant strain, which means that one-third contained the original strain of COVID-19 against which the vaccines are highly effective. Approximately 36% of variants sequenced were BA.5; BA.2 still accounted for more at around 50%. While the current vaccines may be less effective against protecting against infection if you get the BA.5 variant strain, they still offer some level of protection. The vaccines also remain highly effective at preventing more severe consequences like serious illness, hospitalization and death against all variants.  This is where getting a booster when eligible becomes particularly important. As immunity from your initial vaccine doses wane, the boosters become critical to increasing your antibody level and continue to provide your best chances at protection against serious illness. Some people who have not gotten either their first or second booster plan to just wait for the expected updated vaccines in the fall.  The CDC and White House advisors urge people not to wait, indicating that getting your booster now will not exclude you from getting one in the fall.  Better to have all the protection you can get now – and then by getting all the vaccine doses for which you are eligible.

You are eligible for a booster dose if you:

• Are 5+ and it has been 5 months since your second dose of Pfizer.
• Are 18+ and it has been 5 months since your second dose of Moderna.
• Are 18+ and it has been 2 months since your initial dose of Johnson & Johnson.
• Qualified for an “additional/third” dose of Pfizer or Moderna because you have certain immunocompromising conditions.
• You can get your second booster (fourth) dose four months after receiving your initial booster if you are 50+ or are immunocompromised.

Getting vaccinated and boosted when you are eligible remains one of the key ways to Stay One Step Ahead of COVID-19 in our state. View materials that are available for download or ordering free at covidmaterialsde.com.  .

COVID-19 Cases and Hospitalizations:

• Total positive cases since March 11, 2020: 289,266*
• 7-day daily average of new positive cases: 306.7 an increase of 46.8 average new positive cases reported since June 17, 2022
• 7-day daily average for the percentage of total positive tests: 17.5 percentage points, an increase of 3.4 percentage points reported since June 17, 2022
• Hospitalizations: 127, current hospitalizations; critically ill: 14
• Total COVID-19 deaths: 3,008, an increase of 31 since last month, including 25 deaths from a review of vital statistics 

*Case and testing data are based on reporting of lab-confirmed COVID-19 tests only. The number of COVID-19 cases in the community is likely higher than what is reported.

Now some of our youngest Delawareans are eligible to be vaccinated. On June 18, the CDC gave final authorization to both the Pfizer and Moderna vaccines for children ages 6 months through 5 years old, making vaccines available to everyone ages 6 months and older. Additionally, the following week, the CDC authorized Moderna’s vaccines for children ages 6 – 17. Pfizer’s vaccine for this age group was already authorized. Just this week, the FDA granted full approval for Pfizer’s vaccine for ages 12-15. Information about the vaccine and where you can get your child vaccinated is available at de.gov/youthvaccine

COVID-19 Vaccinations:  

• Total number of doses administered in Delaware: 1,855,875
• Percentage of Delawareans 5+ who are fully vaccinated (CDC data): 74.4% 
• Percentage of Delawareans 12+ who are fully vaccinated (CDC data): 78.5%  
• Percentage of Delawareans 18+ who are fully vaccinated (CDC data): 80% 
• Percent of Delawareans who are fully vaccinated (CDC data): 70.2%  

All qualifying Delawareans should get vaccinated. For a location near you, visit de.gov/getmyvaccine. Delaware’s latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healthycommunity.  

COVID-19 Case Vaccination Status Report:

The following reports capture a weekly breakdown of non-boosted cases, deaths, and hospitalizations for the time frame of July 04 – July 10, 2022.

 

1.  Non-boosted: Case – Hospital – Death

Weekly Overview (07/04/22 – 07/10/22)
Non-boosted Cases
Total Non-boosted Cases	1249
Total Cases	1888
Percent of Non-boosted Cases	66%
Non-boosted Hospitalized Cases
Total Non-boosted Hospitalized Cases	88
Total Hospitalized Cases	135
Percent of Non-boosted Cases	65%
Non-boosted Deaths
Total Non-boosted Deaths	0
Total COVID-19 Deaths	2
Percent of Non-boosted Deaths	0%

 

Long-term Care Statistics:  

As of Thursday, July 14, 2022, there have been a total of 4,150 positive COVID-19 cases involving long-term care residents, and 969 residents of Delaware long-term care facilities have died from complications related to COVID-19.  

Resources:  

Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:  

• Monday – Friday: 8:00 a.m. to 9:00 p.m.  
• Saturday: 9:00 a.m. to 5:00 p.m.  

Medically related questions regarding testing, symptoms, and health-related guidance can be submitted by email at DPHCall@delaware.gov.  

DPH will continue to update the public as more information becomes available. For the latest on Delaware’s response, go to de.gov/coronavirus.  

### 

Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com. 

The Delaware Department of Health and Social Services is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.

DOVER, DE (May 21, 2022) – The Delaware Division of Public Health (DPH) reports an increase in COVID-19 cases since the previous monthly COVID-19 update released on April 22, 2022. While COVID-19 cases are increasing in Delaware, hospitalizations and deaths remain significantly lower when compared to the winter surge. DPH continues to encourage Delawareans to get tested if they exhibit symptoms of COVID-19 or have been exposed to someone who tested positive. Although there are no Delaware or federal government mask mandates, individuals are encouraged to mask in public indoor areas in Delaware. Delawareans are also reminded to get boosted to increase their individual protection against COVID-19. Staying up to date with your vaccinations is the best way to ensure your body is prepared to fight against severe cases of COVID-19.

You are eligible for a booster dose if you:

• Are 5+ and it has been 5 months after your second dose of Pfizer
• Are 18+ and it has been 5 months after second dose of Moderna
• Are 18+ and it has been 2 months since your initial dose of Johnson & Johnson
• Qualified for an “additional/fourth” dose of Pfizer or Moderna because you have certain immunocompromising conditions or are age 50 and older. You can get your booster (fourth) dose 6 months after receiving your additional/third dose
• Follow https://coronavirus.delaware.gov/vaccine/where-can-i-get-my-vaccine/#publichealth for locations to receive booster shots

COVID-19 Cases and Hospitalizations:

• Total positive cases since March 11, 2020: 271,294
• 7-day daily average of new positive cases: 574.7, a difference of 417.6 average new positive cases reported since April 22, 2022
• 7-day daily average for the percentage of total positive tests: 19.0 percentage points, a difference of 11.4 percentage points reported since April 22, 2022
• Hospitalizations: 127, current hospitalizations; critically ill: 13
• Total COVID-19 deaths: 2,939 an increase of 43 since last month
• Total COVID-19 deaths reported since April 22, 2022: 43 deaths; 9 regularly reported deaths, 34 deaths from a review of vital statistics

COVID-19 Vaccinations:  

• Total number of doses administered in Delaware: 1,805,255 
• Percentage of Delawareans 5+ who are fully vaccinated (CDC data): 73.6% 
• Percentage of Delawareans 12+ who are fully vaccinated (CDC data): 77.8%  
• Percentage of Delawareans 18+ who are fully vaccinated (CDC data): 79.3% 
• Percent of Delawareans who are fully vaccinated (CDC data): 69.5%  

All qualifying Delawareans should get vaccinated. For a location near you, visit de.gov/getmyvaccine. Delaware’s latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healthycommunity.  

  

COVID-19 Case Vaccination Status Report:  

The following reports capture a weekly breakdown of non-boosted cases, deaths, and hospitalizations for the time frame of May 09 – May 15, 2022. 

 

Weekly Overview (05/09/22 – 05/15/22)
Non-boosted Cases
Total Non-boosted Cases	2406
Total Cases	3464
Percent of Non-boosted Cases	69%
Non-boosted Hospitalized Cases
Total Non-boosted Hospitalized Cases	127
Total Hospitalized Cases	179
Percent of Non-boosted Cases	71%
Non-boosted Deaths
Total Non-boosted Deaths	3
Total COVID-19 Deaths	5
Percent of Non-boosted Deaths	60%

 

Long-term Care Statistics:  

As of Thursday, May 19, 2022, there have been a total of 3,890 positive COVID-19 cases involving long-term care residents, and 956 residents of Delaware long-term care facilities have died from complications related to COVID-19.  

Flu Update: 

DPH reminds the public that flu season is not over.  There were 126 laboratory-confirmed cases reported the week of May 8-May 14. As of May 20, 2022, the most recent date for which flu statistics are available. There have been 2,341 laboratory-confirmed cases for the current season, an increase of 633 since April 22, 2022. The cases involved 1,103 individuals from New Castle County, 518 from Kent County and 720 from Sussex County. This number reflects only the number of lab-confirmed cases; the actual number of cases circulating statewide is likely higher as not all people with the flu seek treatment, and many cases are diagnosed through rapid test kits in a provider’s office versus a lab. There may be technical discrepancies in reporting numbers week to week due to retroactive reporting of cases.

All individuals 6 months and older may still get vaccinated against the flu if they haven’t already. Flu vaccines are available at pharmacies (including those in grocery stores), participating medical provider offices, Federally Qualified Health Centers (for their patients), as well as Division of Public Health clinics. DPH is also advising the public that the flu vaccine can be administered at the same time as the COVID-19 vaccine. 

For the latest information on the flu in Delaware, visit flu.delaware.gov. 

Resources:  

Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:  

Monday – Friday: 8:00 a.m. to 9:00 p.m.  

Saturday: 9:00 a.m. to 5:00 p.m.  

Medically related questions regarding testing, symptoms, and health-related guidance can be submitted by email at DPHCall@delaware.gov.  

Delawareans 18 or older are encouraged to download COVID Alert DE, Delaware’s free exposure notification app to help protect your neighbors while ensuring your privacy. Download on the App Store or Google Play.  

DPH will continue to update the public as more information becomes available. For the latest on Delaware’s response, go to de.gov/coronavirus.    

### 

Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com. 

The Delaware Department of Health and Social Services is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.